Mesoblast (MESO) Revenue Growth (1y) (2017 - 2023)
Mesoblast (MESO) Revenue Growth (1y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 64.30% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -257.89% |
| Mar 31, 2023 | -3.58% |
| Dec 31, 2022 | -44.00% |
| Sep 30, 2022 | -8.38% |
| Jun 30, 2022 | 70.14% |
| Mar 31, 2022 | 2.71% |
| Dec 31, 2021 | 57.79% |
| Sep 30, 2021 | 85.59% |
| Jun 30, 2021 | -92.39% |
| Mar 31, 2021 | -5.91% |
| Dec 31, 2020 | 13.81% |
| Sep 30, 2020 | -30.29% |
| Jun 30, 2020 | 1,233.71% |
| Mar 31, 2020 | 99.71% |
| Dec 31, 2019 | 61.79% |
| Sep 30, 2019 | 70.96% |
| Jun 30, 2019 | 15.71% |
| Mar 31, 2019 | 5.15% |
| Dec 31, 2018 | -79.37% |
| Sep 30, 2018 | -6.73% |